Terns Pharmaceuticals (TERN) Short Interest Ratio & Short Volume $7.99 -0.44 (-5.22%) Closing price 04:00 PM EasternExtended Trading$7.99 0.00 (0.00%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Terns Pharmaceuticals Short Interest DataTerns Pharmaceuticals (TERN) has a short interest of 8.31 million shares, representing 11.94% of the float (the number of shares available for trading by the public). This marks a 5.73% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.8, indicating that it would take 7.8 days of the average trading volume of 1.16 million shares to cover all short positions.Current Short Interest8,310,000 sharesPrevious Short Interest7,860,000 sharesChange Vs. Previous Month+5.73%Dollar Volume Sold Short$59.25 millionShort Interest Ratio7.8 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares87,511,000 sharesFloat Size69,580,000 sharesShort Percent of Float11.94%Today's Trading Volume1,255,521 sharesAverage Trading Volume1,155,490 sharesToday's Volume Vs. Average109% Short Selling Terns Pharmaceuticals? Sign up to receive the latest short interest report for Terns Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTERN Short Interest Over TimeTERN Days to Cover Over TimeTERN Percentage of Float Shorted Over Time Terns Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20258,310,000 shares $59.25 million +5.7%11.9%7.8 $7.13 8/31/20257,860,000 shares $54.71 million +10.4%11.3%7.4 $6.96 8/15/20257,120,000 shares $50.20 million +5.8%10.2%7.2 $7.05 7/31/20256,730,000 shares $39.24 million +11.8%9.7%7.4 $5.83 7/15/20256,020,000 shares $30.40 million -1.6%9.1%6.7 $5.05 6/30/20256,120,000 shares $22.83 million +3.0%9.2%6.4 $3.73 6/15/20255,940,000 shares $23.05 million +9.2%8.9%5.9 $3.88 5/31/20255,440,000 shares $16.97 million -0.4%8.2%5.3 $3.12 5/15/20255,460,000 shares $15.23 million +0.7%8.2%5.3 $2.79 4/30/20255,420,000 shares $17.89 million -2.9%8.3%4.7 $3.30 Get the Latest News and Ratings for TERN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Terns Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/15/20255,580,000 shares $13.39 million -3.3%8.6%4.2 $2.40 3/31/20255,770,000 shares $15.93 million -3.0%8.8%4 $2.76 3/15/20255,950,000 shares $18.92 million -3.9%9.1%3.9 $3.18 2/28/20256,190,000 shares $22.84 million +4.6%9.7%3.7 $3.69 2/15/20255,920,000 shares $24.04 million -8.2%9.3%3.4 $4.06 1/31/20256,450,000 shares $28.77 million -15.6%10.4%3.6 $4.46 1/15/20257,640,000 shares $35.37 million +3.7%12.3%4.5 $4.63 12/31/20247,370,000 shares $40.83 million +18.9%11.8%4.6 $5.54 12/15/20246,200,000 shares $41.73 million +15.0%10.0%3.9 $6.73 11/30/20245,390,000 shares $33.63 million +35.4%8.7%2.9 $6.24 11/15/20243,980,000 shares $24.56 million -12.3%6.4%2 $6.17 10/31/20244,540,000 shares $31.14 million +4.4%7.2%2.4 $6.86 10/15/20244,350,000 shares $33.06 million -11.4%6.9%2.3 $7.60 9/30/20244,910,000 shares $40.95 million +30.6%8.3%2.5 $8.34 9/15/20243,760,000 shares $33.67 million +41.4%6.4%1.9 $8.96 8/31/20242,660,000 shares $20.27 million +47.8%5.6%1.5 $7.62 8/15/20241,800,000 shares $12.10 million -32.1%3.8%1.4 $6.72 7/31/20242,650,000 shares $20.54 million +33.2%5.5%2.2 $7.75 7/15/20241,990,000 shares $19.88 million -26.0%4.6%1.7 $9.99 6/30/20242,690,000 shares $18.32 million +17.0%6.3%2.6 $6.81 6/15/20242,300,000 shares $18.86 million +8.0%5.4%2.4 $8.20 5/31/20242,130,000 shares $12.80 million -4.5%5.0%2.3 $6.01 5/15/20242,230,000 shares $13.36 million -50.3%5.2%2.4 $5.99 4/30/20244,490,000 shares $22.67 million +2.1%10.9%4.9 $5.05 4/15/20244,400,000 shares $22.26 million -2.0%10.7%5 $5.06 3/31/20244,490,000 shares $29.45 million +6.2%10.9%5 $6.56 3/15/20244,230,000 shares $30.46 million -3.4%10.7%5.3 $7.20 2/29/20244,380,000 shares $32.06 million +0.5%11.6%5.9 $7.32 2/15/20244,360,000 shares $32.18 million +2.8%11.5%7.1 $7.38 1/31/20244,240,000 shares $21.96 million -3.4%10.8%7.7 $5.18 1/15/20244,390,000 shares $25.73 million -7.0%11.1%8 $5.86 12/31/20234,720,000 shares $30.63 million +6.8%11.9%9.2 $6.49 12/15/20234,420,000 shares $28.07 million -8.1%11.2%8.8 $6.35 11/30/20234,810,000 shares $21.40 million -5.7%12.2%9.2 $4.45 11/15/20235,100,000 shares $19.64 million -2.5%13.0%11.1 $3.85 10/31/20235,230,000 shares $27.51 million -9.0%13.4%9.7 $5.26 10/15/20235,750,000 shares $30.48 million +5.1%14.7%9.8 $5.30 9/30/20235,470,000 shares $27.51 million +3.0%14.0%9.2 $5.03 9/15/20235,310,000 shares $27.19 million +11.1%14.3%6.5 $5.12 8/31/20234,780,000 shares $25.19 million +0.6%12.8%5.5 $5.27 8/15/20234,750,000 shares $29.50 million +8.2%12.7%5.2 $6.21 7/31/20234,390,000 shares $31.70 million -0.2%12.9%5 $7.22 7/15/20234,400,000 shares $35.86 million +1.6%13.0%5.5 $8.15 6/30/20234,330,000 shares $37.89 million +26.2%12.7%5.7 $8.75 6/15/20233,430,000 shares $39.38 million +9.9%10.1%5.3 $11.48 5/31/20233,120,000 shares $33.10 million +5.1%9.2%6.9 $10.61 5/15/20232,970,000 shares $35.25 million +3.5%8.7%7.2 $11.87 4/30/20232,870,000 shares $37.45 million +8.3%8.5%7.7 $13.05 4/15/20232,650,000 shares $30.50 million +5.6%7.8%7.2 $11.51 3/31/20232,510,000 shares $29.72 million +28.7%8.2%7.4 $11.84 3/15/20231,950,000 shares $17.96 million +15.4%7.7%6.2 $9.21 2/28/20231,690,000 shares $17.12 million -4.0%6.7%5.4 $10.13 2/15/20231,760,000 shares $18.13 million +53.0%7.0%4.4 $10.30 1/31/20231,150,000 shares $10.43 million +10.6%4.3%3.4 $9.07 1/15/20231,040,000 shares $9.40 million -14.1%3.9%3.5 $9.04 12/30/20221,210,000 shares $12.32 million +57.7%4.5%4.1 $10.18 12/15/2022767,400 shares $5.23 million +40.6%4.1%2.7 $6.82 11/30/2022545,800 shares $4.24 million +7.4%3.7%2.3 $7.77 11/15/2022508,000 shares $2.39 million -1.4%3.8%2.8 $4.71 10/31/2022515,100 shares $3.56 million +18.5%3.2%1.3 $6.91 10/15/2022434,600 shares $2.96 million +2.3%2.7%1.1 $6.81 9/30/2022425,000 shares $2.50 million +30.2%2.7%1.1 $5.89 9/15/2022326,400 shares $2.10 million +116.5%2.0%0.9 $6.42 8/31/2022150,800 shares $588.12 thousand +154.7%0.9%0.4 $3.90 8/15/202259,200 shares $260.48 thousand +3.1%0.3%0.2 $4.40 7/31/202257,400 shares $122.26 thousand -22.2%0.5%0.4 $2.13 7/15/202273,800 shares $185.98 thousand -24.2%0.7%0.4 $2.52 6/30/202297,300 shares $241.30 thousand -80.5%0.9%0.6 $2.48 6/15/2022499,900 shares $954.81 thousand +3.4%4.4%2.9 $1.91 5/31/2022483,300 shares $836.11 thousand +0.9%3.8%3.5 $1.73 5/15/2022479,100 shares $723.44 thousand +28.7%3.8%6.3 $1.51 4/30/2022372,300 shares $595.68 thousand -7.5%2.8%5.3 $1.60 4/15/2022402,400 shares $1.03 million +13.6%3.0%6.5 $2.57 3/31/2022354,300 shares $1.05 million -3.1%2.7%6.4 $2.97 3/15/2022365,600 shares $1.07 million -9.8%2.7%6.7 $2.93 2/28/2022405,300 shares $1.35 million +0.3%3.1%6.4 $3.32 2/15/2022404,300 shares $1.61 million +13.2%3.0%5.9 $3.99 1/31/2022357,100 shares $2.24 million -17.3%2.7%5.3 $6.27 1/15/2022431,600 shares $2.52 million -26.3%3.2%6.2 $5.85 12/31/2021585,900 shares $4.14 million -1.6%4.4%8.6 $7.07 12/15/2021595,100 shares $3.67 million -8.2%4.5%9.4 $6.17 11/30/2021648,400 shares $4.90 million +0.1%4.9%10.3 $7.55 11/15/2021647,600 shares $5.50 million -5.4%4.9%10.7 $8.49 10/29/2021684,200 shares $6.50 million -3.5%5.1%10.2 $9.50 10/15/2021708,900 shares $6.95 million +1.0%5.3%10.9 $9.81 9/30/2021702,100 shares $7.32 million +1.9%5.3%10.5 $10.42 9/15/2021689,000 shares $7.38 million +2.4%5.2%9.4 $10.71 8/31/2021673,000 shares $9.06 million +6.0%5.1%8.5 $13.46 8/13/2021634,800 shares $6.86 million No Change4.8%8.3 $10.81 TERN Short Interest - Frequently Asked Questions What is Terns Pharmaceuticals' current short interest? Short interest is the volume of Terns Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 8,310,000 shares of TERN short. 11.94% of Terns Pharmaceuticals' shares are currently sold short. Learn More on Terns Pharmaceuticals' current short interest. What is a good short interest ratio for Terns Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TERN shares currently have a short interest ratio of 8.0. Learn More on Terns Pharmaceuticals's short interest ratio. Which institutional investors are shorting Terns Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Terns Pharmaceuticals: Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Terns Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.94% of Terns Pharmaceuticals' floating shares are currently sold short. Is Terns Pharmaceuticals' short interest increasing or decreasing? Terns Pharmaceuticals saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 8,310,000 shares, an increase of 5.7% from the previous total of 7,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Terns Pharmaceuticals' float size? Terns Pharmaceuticals currently has issued a total of 87,510,000 shares. Some of Terns Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Terns Pharmaceuticals currently has a public float of 69,580,000 shares. How does Terns Pharmaceuticals' short interest compare to its competitors? 11.94% of Terns Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Terns Pharmaceuticals: Organon & Co. (5.29%), Mineralys Therapeutics, Inc. (14.99%), Alvotech (1.35%), ImmunityBio, Inc. (8.95%), Bausch Health Cos Inc. (2.42%), Catalyst Pharmaceuticals, Inc. (7.07%), Tarsus Pharmaceuticals, Inc. (18.08%), IDEAYA Biosciences, Inc. (11.73%), Beam Therapeutics Inc. (25.21%), Cidara Therapeutics, Inc. (11.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Terns Pharmaceuticals stock? Short selling TERN is an investing strategy that aims to generate trading profit from Terns Pharmaceuticals as its price is falling. TERN shares are trading down $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Terns Pharmaceuticals? A short squeeze for Terns Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TERN, which in turn drives the price of the stock up even further. How often is Terns Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TERN, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies Organon & Co. Short Squeeze Mineralys Therapeutics Short Squeeze Alvotech Short Squeeze ImmunityBio Short Squeeze Bausch Health Cos Short Squeeze Catalyst Pharmaceuticals Short Squeeze Tarsus Pharmaceuticals Short Squeeze IDEAYA Biosciences Short Squeeze Beam Therapeutics Short Squeeze Cidara Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TERN) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
